ORIX Corporation
NYSE:IXFinancial - Credit Services
+$0.45 today
- Market cap
- $36.76B
- Beta
- 0.73
- P/E (TTM)
- 15.7
- EPS (TTM)
- $412.82
- Dividend yield
- 2.42%
Volume 0.30M
Average 0.36M
IX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
ORIX CorporationNYSE: IX
Capital Expenditures · Q1 FY2027 · quarter ended Jun 2026
Capital expenditures outflow grows to ¥0
Q1 FY2027 capital expenditures was ¥0, compared with ¥0 a year earlier. Trailing-twelve-month capital expenditures was -¥79.6B. Over 3 fiscal years it compounded at +134.3% a year.
Context
- Capital expenditures amounted to 37.7% of revenue in FY2026, up 35.3 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near ¥0 or moves back toward the trailing-twelve-month quarterly average of -¥19.9B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
JPY · from the cash flow
- Latest · FY2026
- (1.33T) JPY
- Year-over-year change
- -1829.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | (1.33T) | -1829.3% |
| FY2025 | 2025-03-31 | (69.06B) | +9.9% |
| FY2024 | 2024-03-31 | (76.67B) | +26.0% |
| FY2023 | 2023-03-31 | (103.57B) | -133.8% |
| FY2022 | 2022-03-31 | (44.3B) | — |
Capital Expenditures vs competitors
How IX compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Capital expenditures amounts to 2.3% of revenue for IX, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥79.6B JPY | — | +134.3% | 2.3% | |
| LTM Jun 2026 | $295.01M USD | +40.3% | +32.7% | 5.3% | |
| LTM Sep 2026 | $65.05M USD | +31.1% | +15.6% | 1.5% | |
| LTM Mar 2026 | $11.23M USD | +37.2% | +1.3% | 0.4% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding IX) | — | +37.2% | +15.6% | 0.4% | |
Competitors are the stored peer set for IX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 312.14B | 290.4B | 346.13B | 351.63B | 458.33B |
| Depreciation & Amortization | 320.34B | 340.25B | 364.24B | 399.53B | 404.79B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 90.39B |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 135.98B | (177.72B) | 196.52B | 174.77B | 380.73B |
| Accounts Receivables | 3.56B | 12.95B | 5.24B | (2.64B) | 4.56B |
| Inventory | (7.05B) | (17.53B) | (58.13B) | (9.84B) | 0 |
| Accounts Payables | 14.94B | (12.17B) | (4.43B) | (3.91B) | 0 |
| Other Working Capital | 124.53B | (160.97B) | 253.84B | 191.16B | 376.17B |
| Other Non-Cash Items | 266.5B | 428.3B | 344.55B | 345.78B | 35.33B |
| Operating Cash Flow | 1.03T | 881.23B | 1.25T | 1.27T | 1.37T |
| Capital Expenditures | (44.3B) | (103.57B) | (76.67B) | (69.06B) | (1.33T) |
| Acquisitions (Net) | 189.2B | (249.22B) | 112.55B | 24.23B | (89.34B) |
| Purchases of Investments | (1.53T) | (1.61T) | (1.92T) | (2.13T) | (668.84B) |
| Sales of Investments | 596.39B | 742.55B | 586.34B | 1.05T | 776.44B |
| Other Investing Activities | 2.18B | 83.46B | (60.61B) | (178.74B) | 199.5B |
| Investing Cash Flow | (784.99B) | (1.14T) | (1.36T) | (1.31T) | (1.11T) |
| Debt Repayment | (121.49B) | 687.52B | 51.82B | 132.65B | (6.39B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (50B) | (52.07B) | (50B) | (53.52B) | (150B) |
| Dividends Paid | (99.4B) | (106.29B) | (99.9B) | (135.59B) | (170.8B) |
| Other Financing Activities | (59.59B) | (48.46B) | (2.9B) | 202.72B | 166.66B |
| Financing Cash Flow | (330.47B) | 480.7B | (100.99B) | 146.27B | (160.54B) |
| Effect of Forex Changes | 92.75B | 54.03B | 25.24B | 25.34B | 34.76B |
| Net Change in Cash | 12.24B | 275.1B | (181.6B) | 136.68B | 129.12B |
| Free Cash Flow | 990.65B | 777.66B | 1.17T | 1.2T | 37.13B |
ORIX Corporation
NYSE:IX
Intrinsic Alpha fair value
Locked
Current Price
$33.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.